OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.385
-0.035 (-1.45%)
Mar 31, 2025, 10:47 AM EDT - Market open
OmniAb Revenue
In the year 2024, OmniAb had annual revenue of $26.39M, down -22.75%. OmniAb had revenue of $10.80M in the quarter ending December 31, 2024, with 124.06% growth.
Revenue (ttm)
$26.39M
Revenue Growth
-22.75%
P/S Ratio
9.39
Revenue / Employee
$231,500
Employees
114
Market Cap
291.29M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OABI News
- 12 days ago - OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
- 5 weeks ago - OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 - Business Wire
- 7 weeks ago - OmniAb to Participate in Two Investor Conferences in March - Business Wire
- 2 months ago - Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm - PRNewsWire
- 3 months ago - OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference - Business Wire
- 4 months ago - OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - Business Wire